Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production
- 4 September 2002
- Vol. 21 (5-6) , 549-561
- https://doi.org/10.1016/s0264-410x(02)00394-8
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Sublingual immunotherapyJournal of Allergy and Clinical Immunology, 2001
- Molecular pathology of allergic diseaseJournal of Allergy and Clinical Immunology, 2000
- Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats☆☆☆★★★Journal of Allergy and Clinical Immunology, 1998
- Role of interleukin 10 in specific immunotherapy.Journal of Clinical Investigation, 1998
- Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice.Journal of Clinical Investigation, 1995
- Overlapping T-cell epitopes in the group I allergen of species restricted by HLA-DP and HLA-DR class II moleculesJournal of Allergy and Clinical Immunology, 1994
- Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals.The Journal of Experimental Medicine, 1993
- Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice.The Journal of Experimental Medicine, 1993
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992
- Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavityJournal of Allergy and Clinical Immunology, 1991